Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2019-05-10 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
108年第1季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the first quarter of the fiscal year 108 (which corresponds to 2019 in the Gregorian calendar). It includes detailed financial data such as net profit before tax, depreciation, amortization, changes in receivables, payables, and cash flows from operating, investing, and financing activities. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is 2125 characters, which is relatively short but contains detailed financial data, so it is not merely an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2019
2019-05-10 Chinese
108年第1季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement for the first quarter of the year 108 (Taiwanese calendar, corresponding to 2019). It includes detailed financial data such as revenue, costs, expenses, net profit, and earnings per share for the period from January 1 to March 31. The presence of actual financial figures and the quarterly period covered indicate this is a financial report for a period shorter than a full fiscal year. The document length is 1936 characters, which is relatively short but contains substantive financial data, not just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-05-10 Chinese
108年第1季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific asset, liability, and equity line items with amounts and percentages. The data is for the first quarter of the year 108 (Taiwan calendar, corresponding to 2019). The presence of detailed financial statements with actual figures indicates this is a financial report rather than an announcement or summary. The length is 3886 characters, which is relatively short but contains substantive financial data. Given it is a quarterly period and contains comprehensive financial data, this fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-05-10 Chinese
108年第1季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data specifically a consolidated statement of changes in equity for a company, with figures for the current and previous periods. It includes accounting items such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, foreign currency translation adjustments, treasury stock, and total equity attributable to the parent company and non-controlling interests. The data is presented for a quarterly period (民國108年第1季, which corresponds to the first quarter of 2019). The document length is 3468 characters, which is relatively short but contains substantive financial data rather than just an announcement or a link to a report. This matches the definition of an Interim / Quarterly Report (IR), which must contain actual financial statements or substantive financial data and analysis for a period shorter than a full fiscal year. There is no indication that this is a full annual report or just an announcement or certification. Therefore, the document is best classified as an Interim / Quarterly Report (IR). Q1 2019
2019-05-10 Chinese
108年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (科妍) providing information about fund lending balances and endorsement guarantees for the current and previous months, with amounts all zero. It is a regulatory disclosure of financial status related to guarantees and loans, typical of routine regulatory filings in Taiwan's public information observation station. The document is short (601 characters) and contains no detailed financial statements or analysis, nor does it announce or attach a report. It is not an annual or interim report, nor a management or earnings release. It fits best as a Regulatory Filing (RNS) as a general compliance disclosure.
2019-05-10 Chinese
108年4月營業收入
Regulatory Filings Classification · 90% confidence The document is a revenue summary report for a company named 科妍 for the month and year indicated as 民國108年04月 (which corresponds to April 2019). It provides monthly and cumulative net operating revenue figures, percentage changes compared to the previous year, and explanations for revenue changes. The document is short (771 characters) and contains financial data but is not a comprehensive financial report like an annual or interim report. It appears to be a regulatory disclosure of monthly revenue figures, typical of a regulatory filing or a brief financial update. There is no indication that this is a full financial report, audit report, or earnings release. Given the nature and length, and that it is a regulatory disclosure of financial data, the best fit is Regulatory Filings (RNS).
2019-05-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.